Literature DB >> 29306556

Sarcomatoid renal cell carcinoma: Biology and treatment advances.

Nemer El Mouallem1, Steven C Smith2, Asit K Paul3.   

Abstract

Sarcomatoid transformation in renal cell carcinoma, so called sacromatoid RCC (sRCC), is associated with an aggressive behavior and a poor prognosis. Current therapeutic approaches are largely ineffective. Recent studies looking into the genomic and molecular characterization of sRCCs have provided insights into the biology and pathogenesis of this entity. These advances in molecular signatures may help development of effective treatment strategies. We herein present a review of recent developments in the pathology, biology, and treatment modalities in sRCC.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Immunotherapy; Nephrectomy; Renal cell carcinoma; Sarcomatoid renal cell carcinoma; Targeted therapy

Mesh:

Year:  2018        PMID: 29306556     DOI: 10.1016/j.urolonc.2017.12.012

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  13 in total

Review 1.  Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma.

Authors:  Mamta Parikh; Poornima Bajwa
Journal:  Semin Nephrol       Date:  2020-01       Impact factor: 5.299

Review 2.  Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.

Authors:  Nicolas A Giraldo; J David Peske; Catherine Sautès-Fridman; Wolf H Fridman
Journal:  Virchows Arch       Date:  2019-01-10       Impact factor: 4.064

3.  The Role of Cytoreductive Nephrectomy and Targeted Therapy on Outcomes of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Population-Based Analysis.

Authors:  Taha Al-Juhaishi; Xiaoyan Deng; Dipankar Bandyopadhyay; Asit Paul
Journal:  Cureus       Date:  2022-05-27

4.  A Rare Case of Sarcomatoid Renal Cell Carcinoma in a Young Adult Patient.

Authors:  Syah Mirsya Warli; Andy Andy; Causa Trisna Mariedina; Ramlan Nasution; Dhirajaya Dharma Kadar
Journal:  Res Rep Urol       Date:  2022-06-16

5.  Prognostic Significance of Sarcomatoid Differentiation in Patients With Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Hong Zhi; Meiling Feng; Suo Liu; Ta Na; Nandong Zhang; WuEn BiLiGe
Journal:  Front Oncol       Date:  2020-10-08       Impact factor: 6.244

6.  LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.

Authors:  Chao Han; Bin Xu; Lin Zhou; Long Li; Chao Lu; Guo-Peng Yu; Yu-Shan Liu
Journal:  Onco Targets Ther       Date:  2020-10-09       Impact factor: 4.147

7.  Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126.

Authors:  Tao Huang; Xiao Wang; Xiaokun Yang; Jianlei Ji; Qinghai Wang; Xuan Yue; Zheng Dong
Journal:  Med Sci Monit       Date:  2018-10-14

8.  Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.

Authors:  Bin Yang; Haizhui Xia; Chuxiao Xu; Min Lu; Shudong Zhang; Guoliang Wang; Lulin Ma
Journal:  BMC Urol       Date:  2020-02-18       Impact factor: 2.264

9.  Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

Authors:  Renata Colombo Bonadioa; Pedro Isaacsson Velho; Guilherme Nader Marta; Mirella Nardo; Manoel Carlos LA Souza; David Qb Muniz; Regis Of Bezerra; Raisa Ka Bispo; Sheila F Faraj; Diogo A Bastos; Carlos Dzik
Journal:  Ecancermedicalscience       Date:  2019-11-04

10.  Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade.

Authors:  Robert J Motzer; Romain Banchereau; Habib Hamidi; Thomas Powles; David McDermott; Michael B Atkins; Bernard Escudier; Li-Fen Liu; Ning Leng; Alexander R Abbas; Jinzhen Fan; Hartmut Koeppen; Jennifer Lin; Susheela Carroll; Kenji Hashimoto; Sanjeev Mariathasan; Marjorie Green; Darren Tayama; Priti S Hegde; Christina Schiff; Mahrukh A Huseni; Brian Rini
Journal:  Cancer Cell       Date:  2020-11-05       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.